Thrivent Financial for Lutherans
NTRA icon

Thrivent Financial for Lutherans’s Natera NTRA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio NTRA Stock Details NTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
55,467
+8,919
+19% +$1.92M 0.02% 603
2025
Q4 		$10.7M Sell
46,548
-16,829
-27% -$3.51M 0.02% 647
2025
Q3 		$10.2M Buy
63,377
+10,167
+19% +$1.61M 0.02% 601
2025
Q2 		$8.99M Sell
53,210
-73,991
-58% -$11.5M 0.02% 595
2025
Q1 		$18M Buy
127,201
+11,236
+10% +$1.81M 0.04% 416
2024
Q4 		$18.4M Sell
115,965
-27,938
-19% -$4.07M 0.04% 480
2024
Q3 		$18.3M Buy
143,903
+1,685
+1% +$193K 0.03% 493
2024
Q2 		$15.4M Sell
142,218
-31,424
-18% -$3.19M 0.03% 527
2024
Q1 		$15.9M Buy
173,642
+3,175
+2% +$239K 0.03% 521
2023
Q4 		$10.7M Sell
170,467
-2,868
-2% -$143K 0.02% 623
2023
Q3 		$7.67M Sell
173,335
-64,403
-27% -$3.28M 0.02% 678
2023
Q2 		$11.6M Sell
237,738
-4,031
-2% -$206K 0.03% 598
2023
Q1 		$13.4M Buy
241,769
+8,652
+4% +$415K 0.03% 532
2022
Q4 		$9.36M Buy
233,117
+10,459
+5% +$431K 0.02% 613
2022
Q3 		$9.76M Buy
222,658
+65,686
+42% +$3.13M 0.03% 597
2022
Q2 		$5.56M Buy
156,972
+22,463
+17% +$832K 0.01% 779
2022
Q1 		$5.47M Sell
134,509
-82,840
-38% -$4.98M 0.01% 857
2021
Q4 		$20.3M Buy
217,349
+1,677
+0.8% +$174K 0.04% 464
2021
Q3 		$24M Sell
215,672
-20,561
-9% -$2.36M 0.05% 413
2021
Q2 		$26.8M Sell
236,233
-44,349
-16% -$4.54M 0.05% 381
2021
Q1 		$28.5M Sell
280,582
-13,146
-4% -$1.44M 0.06% 355
2020
Q4 		$29.2M Sell
293,728
-30,804
-9% -$2.57M 0.07% 351
2020
Q3 		$23.4M Buy
324,532
+27,037
+9% +$1.54M 0.06% 361
2020
Q2 		$14.8M Sell
297,495
-76,326
-20% -$3.06M 0.04% 448
2020
Q1 		$11.2M Sell
373,821
-72,185
-16% -$2.41M 0.04% 476
2019
Q4 		$15M Buy
446,006
+47,064
+12% +$1.73M 0.04% 457
2019
Q3 		$13.1M Buy
398,942
+11,880
+3% +$351K 0.04% 435
2019
Q2 		$10.7M Buy
387,062
+51,219
+15% +$1.13M 0.03% 496
2019
Q1 		$6.92M Buy
335,843
+27,279
+9% +$427K 0.02% 588
2018
Q4 		$4.31M Buy
+308,564
New +$5.63M 0.02% 643

Other funds holding NTRA

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thrivent Financial for Lutherans's NTRA Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Natera (NTRA) stake by 19% in Q1 2026, buying an estimated $1.92M and bringing the position to 55,467 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #603.

Thrivent Financial for Lutherans first reported a position in NTRA in Q4 2018 and has held it in 30 quarters since. The position peaked at $29.2M in Q4 2020. 762 funds tracked by Wall St. Rank hold NTRA as of Q1 2026.

  • Thrivent Financial for Lutherans held 55,467 shares of Natera worth $11.1M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 8,919 Natera shares in Q1 2026, an estimated $1.92M.
  • Natera made up 0.02% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #603 holding.
  • Thrivent Financial for Lutherans first reported a position in Natera in Q4 2018 and has held it in 30 quarters since.
  • Thrivent Financial for Lutherans's Natera position peaked at $29.2M in Q4 2020.
  • 762 funds tracked by Wall St. Rank held Natera as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.